Rose D M, Barnhart G R, Jones M
Ann Thorac Surg. 1983 Jan;35(1):79-86. doi: 10.1016/s0003-4975(10)61435-x.
Short-term experimental studies have indicated that initial reperfusion with blood cardioplegia may decrease ischemic injury after aortic occlusion; however, no long-term studies have been performed. We evaluated cardioplegic reperfusion in fifteen dogs, divided into three groups of five each. Group I underwent 2 hours of cardiopulmonary bypass at 37 degrees C. Group II underwent 2 hours of cardiopulmonary bypass, including 1 hour of ischemic arrest, at 25 degrees C. Group III was identical to Group II, but the hearts of the animals were initially reperfused with 500 ml of blood cardioplegia at 25 degrees C (K+ = 30 mEq/L). Stroke work index (SWI), left ventricular end-diastolic pressure (LVEDP), dp/dt max and maximal contractile element velocity (Vpm) were measured preoperatively, immediately after operation, 21 days postoperatively, immediately after operation, 21 days postoperatively and 120 days postoperatively. Compliance curves were evaluated using an intraventricular balloon at 120 days. Groups II and III had significant (p less than 0.05) elevations of LVEDP at all three postoperative measurements. The hearts of the Group III animals (cardioplegic reperfusion group) demonstrated significantly (p less than 0.05 to 0.01) better recovery of SWI immediately after operation (62% versus 39%), at 21 days (85% versus 69%), and at 120 days (81% versus 66%) than did those in Group II. However, groups II and III had decreased compliance at 120 days, compared with that of Group I, and also showed both gross and microscopic evidence of subendocardial necrosis and fibrosis. It is concluded that while initial reperfusion with blood cardioplegia appears to provide better preservation of ventricular function early after ischemic cardiac arrest, this technique does not prevent later deterioration of ventricular compliance. Moreover, it produces myocardial fibrosis.
短期实验研究表明,血液停搏液初始再灌注可能会减少主动脉阻断后的缺血性损伤;然而,尚未进行长期研究。我们评估了15只犬的停搏液再灌注情况,将其分为三组,每组五只。第一组在37℃下进行2小时的体外循环。第二组在25℃下进行2小时的体外循环,包括1小时的缺血性停搏。第三组与第二组相同,但动物心脏在25℃下最初用500毫升血液停搏液(钾离子浓度=30毫当量/升)进行再灌注。术前、术后即刻、术后21天、术后即刻、术后21天和术后120天测量每搏功指数(SWI)、左心室舒张末期压力(LVEDP)、dp/dt最大值和最大收缩成分速度(Vpm)。术后120天时使用心室内球囊评估顺应性曲线。第二组和第三组在术后所有三个测量时间点的LVEDP均显著升高(p<0.05)。第三组动物(停搏液再灌注组)的心脏在术后即刻(62%对39%)、21天时(85%对69%)和120天时(81%对66%)的SWI恢复情况明显优于第二组(p<0.05至0.01)。然而,与第一组相比,第二组和第三组在120天时顺应性降低,并且还显示出心内膜下坏死和纤维化的大体和显微镜证据。结论是,虽然血液停搏液初始再灌注似乎能在缺血性心脏停搏后早期更好地保护心室功能,但该技术并不能防止后期心室顺应性的恶化。此外,它还会导致心肌纤维化。